Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Strontium-89 With or Without Cisplatin for Bone Pain in Prostate Cancer
NCT00156884Phase 2Completed
- Sponsor
- Alberta Health Services
- Start
- Aug 2003
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of cisplatin in prostate cancer (PCa) (2 arms), sponsored by Alberta Health Services. Primary endpoints: Palliative pain response and Analgesic response. Started Aug 2003; status: completed.
02
Drugs
cisplatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00156884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156884.